The Landscape and Regulatory Mechanisms of Aberrant Alternative Splicing Events in Adenomyosis

Aberrant alternative splicing events (AASEs) are associated with numerous diseases; however, little is currently known about AASEs in human adenomyosis, making it essential to understand AS in adenomyosis to clarify its pathogenesis. In this study, we identified 1 022 512 transcripts across transcriptome data from 130 samples (61 adenomyosis patients and 69 controls), including 483 629 novel transcripts not annotated in the reference genome. Additionally, 229236 ASEs were identified, of which 531 were classified as AASEs. Furthermore, we constructed a network of 13 differentially expressed RNA-binding proteins (RBPs) regulating 226 AASEs. Through cis-sQTL (cis-acting Splicing Quantitative Trait Locus) analysis, 14629 sQTLs were detected. Enrichment analysis of the genes containing these sQTLs suggests that their functions are involved in uterine-related disease regulation processes. Moreover, a statistically significant single-nucleotide polymorphism (SNP) (chr4:173588365, P-adjust < 0.05) was identified within lncRNA HAND2-AS1, which is significantly associated with its AS. HAND2-AS1 has been reported to regulate the proliferative capacity and migratory potential of endometrial stromal cells – processes closely linked to the pathogenesis of endometriosis. The results of this study enhance our understanding of the mechanism of AS in adenomyosis and provide a new perspective for further research on adenomyosis. Similar content being viewed by others DATA AVAILABILITY All data generated or analysed during this study are included in this published article and its supplementary information files.

Keren H., Lev-Maor G., Ast G. 2010. Alternative splicing and evolution: Diversification, exon definition and function. Nat. Rev. Genet. 11, 345–355. Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T., Richardson A., Sun S., Yang F., Shen Y.A., Murray R.R., Spirohn K., Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q., Wanamaker S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D., Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J., Salehi-Ashtiani K., Charloteaux B., Chen A.A., Calderwood M.A., Aloy P., Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M. 2016. Widespread expansion of protein interaction capabilities by alternative splicing. Cell. 164, 805–817. Nilsen T.W., Graveley B.R. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature. 463, 457–463. Xu N., Ren Y., Bao Y., Shen X., Kang J., Wang N., Wang Z., Han X., Li Z., Zuo J., Wei G., Wang Z., Zong W., Liu W., Xie G. 2023. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C. Cell Rep. 42, 196–210. Zheng Y., Zhong G., Song Q., Zhang H., Wang S., Lin C., He C., Li M. 2024. Mapping alternative splicing events in colorectal cancer. Discover Oncol. 15, 280. Babic I., Anderson E.S., Tanaka K., Guo D., Masui K., Li B., Zhu S., Gu Y., Villa G.R., Akhavan D., Nathanson D., Gini B., Mareninov S., Li R., Camacho C.E., Kurdistani S.K., Eskin A., Nelson S.F., Yong W.H., Cavenee W.K., Cloughesy T.F., Christofk H.R., Black D.L., Mischel1 P.S. 2013. EGFR Mutation-Induced alternative splicing of max contributes to growth of glycolytic tumors in brain cancer. Cell Metab. 17, 1000–1008. Yang Q., Zhao J., Zhang W., Chen D., Wang Y. 2019. Aberrant alternative splicing in breast cancer. J. Mol. Cell Biol. 11, 920–929. Biamonti G., Amato A., Belloni E., Di Matteo A., Infantino L., Pradella D., Ghigna C. 2021. Alternative splicing in Alzheimer’s disease. Aging Clin. Exp. Res. 33, 747–758. Shehadeh L.A., Yu K., Wang L., Guevara A., Singer C., Vance J., Papapetropoulos S. 2010. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson’s disease. PLoS One. 5, e9104. Fernández-Nogales M., Santos-Galindo M., Hernández I.H., Cabrera J.R., Lucas J.J. 2016. Faulty splicing and cytoskeleton abnormalities in Huntington’s disease. Brain Pathol. 26, 772–778. Dahal L.N., Basu N., Youssef H., Khanolkar R.C., Barker R.N., Erwig L.P., Ward F.J. 2016. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res. Ther. 18, 180. Zhou H., Liu X., Yu R., Long T., Zhao R., Liu H., Xu Y., Liang J.G., Liang P. 2016. Alternative splicing directs two IL-20R2 isoforms and is responsible for the incomplete gene knockout via the exon I ablation. Genes Immun. 17, 220–227. Liu S., Zhao K., Su X., Lu L., Zhao H., Zhang X., Wang Y., Wu C., Chen J., Zhou Y., Hu X., Wang Y., Lu M., Chen X., Pei R. 2017. MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication. PLoS One. 12, e0169701. Zhang Y., Qian J., Gu C., Yang Y. 2021. Alternative splicing and cancer: Asystematic review. Signal Transduct. Target. Ther. 6, 78. Benagiano G., Habiba M., Brosens I. 2012. The pathophysiology of uterine adenomyosis: An update. Fertil. Steril. 98, 572–579. Bergeron C., Amant F., Ferenczy A. 2006. Pathology and physiopathology of adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 20, 511–521. Vercellini P., Consonni D., Dridi D., Bracco B., Frattaruolo M.P., Somigliana E. 2014. Uterine adenomyosis and in vitro fertilization outcome: A systematic review and meta-analysis. Hum. Reprod. 29, 964–977. Naftalin J., Hoo W., Pateman K., Mavrelos D., Foo X., Jurkovic D. 2014. Is adenomyosis associated with menorrhagia? Hum. Reprod. 29, 473–479. Ferenczy A. 1998. Pathophysiology of adenomyosis. Hum. Reprod. Update. 4, 312–322. Benagiano G., Brosens I. 2012. The endometrium in adenomyosis. Women’s Health 8, 301–312. Bourdon M., Santulli P., Jeljeli M., Vannuccini S., Marcellin L., Doridot L., Petraglia F., Batteux F., Chapron C. 2021. Immunological changes associated with adenomyosis: A systematic review. Hum. Reprod. Update. 27, 108–129. GTEx Consortium. 2020. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 369, 1318–1330. Tian J., Chen C., Rao M., Zhang M., Lu Z., Cai Y., Ying P., Li B., Wang H., Wang L., Li Y., Huang j., Fan L., Cai X., Ning C., Li Y., Zhang F., Wang W., Jiang Y., Liu Y., Wang M., Li H., Huang C., Yang Z., Chang J., Zhu Y., Yang X., Miao X. 2022. Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer Res. 82, 2084–2096. Fu R.H., Liu S.P., Huang S.J., Chen H.J., Chen P.R., Lin Y.H., Ho Y.H., Chang W.L., Tsai C.H., Shyu W.C., Lin S.Z. 2013. Aberrant alternative splicing events in Parkinson’s disease. Cell Transplant. 22, 653–661. Sun Y., Hu X. 2024. Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (review). Int. J. Oncol. 65, 90. Garcia-Blanco M.A., Baraniak A.P., Lasda E.L. 2004. Alternative splicing in disease and therapy. Nat. Biotechnol. 22, 535–546. Zhang Y., Zhang Y., Zhao C., Yu T., Liu Y., Shi W., Shi F., Liu X., Sheng J., Huang H., Xu H. 2017. Reduced alternative splicing of estrogen receptor alpha in the endometrium of women with endometriosis. Oncotarget. 8 (66), 110176–110186. Chen S. 2023. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta. 2, e107. Kim D., Paggi J.M., Park C., Bennett C., Salzberg S.L. 2019. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915. Danecek P., Bonfield J.K., Liddle J., Marshall J., Ohan V., Pollard M.O., Whitwham A., Keane T., McCarthy S.A., Davies R.M., Li H. 2021. Twelve years of SAMtools and BCFtools. Gigascience. 10, giab008. Pertea M., Pertea G.M., Antonescu C.M., Chang T.C., Mendell J.T., Salzberg S.L. 2015. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290–295. Pertea G., Pertea M. 2020. GFF Utilities: GffRead and GffCompare. F1000Res. 9, 304. Liao Y., Smyth G.K., Shi W. 2014. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 30, 923–30. Li B., Dewey C.N. 2011. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 12, 323. Love M., Anders S., Huber M. 2014. Differential gene expression analysis based on the negative binomial distribution. Genome Biol. 15, 10–1186. Trincado J.L., Entizne J.C., Hysenaj G., Singh B., Skalic M., Elliott D.J., Eyras E. 2018. SUPPA2: Fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions. Genome Biol. 19, 40. Sebestyén E., Singh B., Miñana B., Pagès A., Mateo F., Pujana M.A., Valcárcel J., Eyras E. 2016. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res. 26, 732–744. Xiao L., Zou G., Cheng R., Wang P., Ma K., Cao H., Zhou W., Jin X., Xu Z., Huang Y., Lin X., Nie H., Jiang Q. 2021. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. BMC Cancer. 21, 703. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. 2003. Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504. Poplin R., Ruano-Rubio V., DePristo M.A., Fennell T.J., Carneiro M.O., Van-der-Auwera G.A., Kling D.E., Gauthier L.D., Levy-Moonshine A., Roazen D., Shakir K., Thibault J., Chandran S., Whelan C., Lek M., Gabriel S., Daly M.J., Neale B., MacArthur D.G., Bankset E. 2018. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 201178. Ongen H., Buil A., Brown A.A., Dermitzakis E.T., Delaneau O. 2016. Fast and efficient QTL mapper for thousands of molecular phenotypes. Bioinformatics. 32, 1479–1485. Li X., Zhao Y., Kong H., Song C., Liu J., Xia J. 2023. Identification of region-specific splicing QTLs in human hippocampal tissue and its distinctive role in brain disorders. iScience. 26. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J, Sklar P., de-Bakker P.I.W., Daly M.J., Sham P.C. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575. Cantalapiedra C.P., Hernández-Plaza A., Letunic I., Bork P., Huerta-Cepas J. 2021. eggNOG-mapper v2: Functional annotation, orthology assignments, and domain prediction at the metagenomic scale. Mol. Biol. Evol. 38, 5825–9. Bu D., Luo H., Huo P., Wang Z., Zhang S., He Z., Wu Y., Zhao L., Liu J., Guo J., Fang S., Cao W., Yi L., Zhao Y., Kong L. 2021. KOBAS-i: Intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 49, W317–W325. Finn R.D., Clements J., Eddy S.R. 2011. HMMER web server: Interactive sequence similarity searching. Nucleic Acids Res. 39, 29–37. Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., Fu X., Liu S., Bo X., Yu G. 2021. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. 2. Villanueva R.A.M., Chen Z.J. 2019. ggplot2: Elegant graphics for data analysis. Meas. Interdiscip. Res. Perspect. 17, 160–167. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature. 456, 470–476. Chabot B., Shkreta L. 2016. Defective control of pre–messenger RNA splicing in human disease. J. Cell Biol. 212, 13–27. Zhang Y., Yang H.T., Kadash-Edmondson K., Pan Y., Pan Z., Davidson B.L., Xing Y. 2020. Regional variation of splicing QTLs in human brain. Am. J. Hum. Genet. 107, 196–210. Kao L.C., Germeyer A., Tulac S., Lobo S., Yang J.P., Taylor R.N., Osteen K., Lessey B.A., Giudice L.C. 2003. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 144, 2870–2881. Li B., Wang S., Duan H., Wang Y., Guo Z. 2021. Discovery of gene module acting on ubiquitin-mediated proteolysis pathway by co-expression network analysis for endometriosis. Reprod. Biomed. Online. 42, 429–441. Gu N.-H., Li G.-J., Yang B.-X., You M., Lin Y., Sun F., Xu H. 2021. Hypo-expression of tuberin promotes adenomyosis via the mTOR1-autophagy axis. Front. Cell Dev. Biol. 9, 710407. Li X., Han M., Zhang H., Liu F., Pan Y., Zhu J., Liao Z., Chen X., Zhang B. 2022. Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma. Biomarker Res. 10, 2. Rotival M., Quach H., Quintana-Murci L. 2019. Defining the genetic and evolutionary architecture of alternative splicing in response to infection. Nat. Commun. 10, 1671. Zheng Y., Wu S., Liu L., Guan Y., Sun W., Miao C., Li Q. 2024. Activation of HAND2–FGFR signaling pathway by lncRNA HAND2-AS1 in adenomyosis. Biol. Reprod. 110, 490–500. Khan K.N., Fujishita A., Mori T. 2022. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J. Clin. Med. 11, 4057. Nikom D., Zheng S. 2023. Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat. Rev. Neurosci. 24, 457–473. Fang Y., Chen G., Chen F., Hu E., Dong X., Li Z., He L., Sun Y., Qiu L., Xu H., Cai Z., Liu X. 2021. Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma. Cancer Sci. 112, 3555–3568. Wang P., Wu X., Shi Z., Tao S., Liu Z., Qi K., Xie Z., Qiao X., Gu C., Yin H., Cheng M., Gu X., Liu X., Tang C., Cao P., Xu S., Zhou B., Gu T., Bian Y., Wu J., Zhang S. 2023. A large-scale proteogenomic atlas of pear. Mol. Plant. 16, 599–615. Zhao P., Meng Q., Wan C., Lei T., Zhang L., Zhang X., Tan L., Zhu H., He X. 2023. Clinical features of CNOT3-associated neurodevelopmental disorder in three Chinese patients. Neurogenetics. 24, 129–136. Honda K., Yamada T., Seike M., Hayashida Y., Idogawa M., Kondo T., Ino Y., Hirohashi S. 2004. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene. 23, 5257–5262. Talluri S., Samur M.K., Buon L., Kumar S., Potluri L.B., Shi J., Prabhala R.H., Shammas M.A., Munshi N.C. 2021. Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma. Blood Cancer J. 11, 166. Bulun S.E., Yildiz S., Adli M., Chakravarti D., Parker J.B., Milad M., Yang L., Chaudhari A., Tsai S., Wei J.J., Yin P. 2023. Endometriosis and adenomyosis: Shared pathophysiology. Fertil. Steril. 119, 746–750. Rada M., Cha J., Sage J., Zhou B., Yang W., Ashkavand Z., Norman K., Orsulic S., Cheon D.-J. 2018. Abstract 3526: Beta-oxidation inhibition as a novel therapy for cisplatin-resistant ovarian cancer. Cancer Res. 78, 3526. Shang Z., Qian L., Liu S., Niu X., Qiao Z., Sun Y., Zhang Y., Fan L.Y., Guan X, Cao C.X., Xiao H. 2018. Graphene oxide-facilitated comprehensive analysis of cellular nucleic acid binding proteins for lung cancer. ACS Appl. Mater. Interfaces. 10, 17756–17770. Chen E.I., Hewel J., Krueger J.S., Tiraby C., Weber M.R., Kralli A., Becker K., Yates III J.R., Felding-Habermann B. 2007. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 67, 1472–1486. Zhang H., Pan E., Zhang Y., Zhao C., Liu Q., Pu Y., Yin L. 2022. LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis. BMC Cancer. 22, 1017. Akin L., Rizzoti K., Gregory L.C., Corredor B., Le-Quesne-Stabej P., Williams H., Buonocore F., Mouilleron S., Capra V., McGlacken-Byrne S.M., Martos-Moreno G.A., Azmanov D.N., Kendirci M., Kurtoglu S., Suntharalingham J.P., Galichet C., Gustincich S., Tasic V., Achermann J.C., Accogli A., Dattani M.T. 2022. Pathogenic variants in RNPC3 are associated with hypopituitarism and primary ovarian insufficiency. Genet. Med. 24, 384–397. Silla T., Karadoulama E., Mąkosa D., Lubas M., Jensen T.H. 2018. The RNA Exosome Adaptor ZFC3H1 functionally competes with nuclear export activity to retain target transcripts. Cell Rep. 23, 2199–2210. Tao Y., Zhang Q., Wang H., Yang X., Mu H. 2024. Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduction Targeted Ther. 9, 26. Cassandri M., Smirnov A., Novelli F., Pitolli C., Agostini M., Malewicz M., Melino G., Raschellà G. 2017. Zinc-finger proteins in health and disease. Cell Death Discovery. 3, 17071. Jen J., Wang Y.-C. 2016. Zinc finger proteins in cancer progression. J. Biomed. Sci. 23, 53. Xu W.P., Liu J.P., Feng J.F., Zhu C.P., Yang Y., Zhou W.P., Ding J., Huang C.K., Cui Y.L., Ding C.H., Zhang X., Lu B., Xie W.F. 2020. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 69, 1309–1321. Dong F., Li C., Wang P., Deng X., Luo Q., Tang X., Xu L. 2018. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells. Exp. Cell Res. 367, 89–96. Li Y., Zhang L., Li K., Li J., Xiang R., Zhang J., Li H., Xu Y., Wei Y., Gao J., Lin P., Wei Y. 2015. ZNF32 inhibits autophagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death. Sci. Rep. 5, 9288. Marinić M., Mika K., Chigurupati S., Lynch V.J. 2021. Evolutionary transcriptomics implicates HAND2 in the origins of implantation and regulation of gestation length. Elife. 10, e61257. Yin X.H., Shi M., Wu H., Zhou L., Xu B. 2017. Role of HAND2 gene and protein expression in endometrial carcinoma. Eur. J. Gynaecol. Oncol. 38, 95–101. Liu L., Dong H., Guan Y., Fan T., Sun W., Bagchi I.C., Miao C., Li Q. 2023. Regulation of HAND2 Expression by LncRNA HAND2-AS1 in ovarian endometriosis involving DNA methylation. J. Endocr. Soc. 7, bvad049. ACKNOWLEDGMENTS Thanks to all colleagues at Women’s Hospital School of Medicine Zhejiang University for their support and help. Funding This work was supported by General Research Project of Zhejiang Provincial Department of Education (Y202454254). Author information Authors and Affiliations Contributions YNZ conceived and designed the experiments. YNZ, ZHC contributed to paper writing. YNZ contributed to the data analysis. All authors reviewed the manuscript. Corresponding author Ethics declarations ETHICS APPROVAL AND CONSENT TO PARTICIPATE This work does not contain any studies involving human and animal subjects. CONFLICT OF INTEREST The authors of this work declare that they have no conflicts of interest. Additional information Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. AI tools may have been used in the translation or editing of this article. Supplementary Information Rights and permissions About this article Cite this article Zhang, Y., Cui, Z. The Landscape and Regulatory Mechanisms of Aberrant Alternative Splicing Events in Adenomyosis. Mol Biol 59 (Suppl 1), S22–S35 (2025). https://doi.org/10.1134/S0026893325602150 Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1134/S0026893325602150